News
The framework the new FDA leaders laid out on Tuesday raised small and big questions about the regulatory process, vaccine ...
Two weeks into his tenure leading the FDA’s biologics center, Vinay Prasad has made his mark with a new framework for ...
The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory ...
The FDA’s new policy limits COVID-19 vaccine eligibility to older adults and high-risk groups, excluding millions from ...
1d
The Palladium-Item on MSNHere's what to know about the FDA's COVID-19 vaccine changesThe FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.
Despite an explanation of the new strategy published Tuesday from FDA Commissioner Marty Makary and Vinay Prasad, who ...
Healthy and under the age of 65? You might not need to receive an annual COVID-19 booster. What to know about new guidelines.
COVID and booster shots were recommended for everyone over 6 months old. But FDA Vaccine Division Chief Dr. Vinay Prasad and ...
U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period ...
1d
Clinical Trials Arena on MSNNavigating the FDA’s accelerated approval pathways for oncology drugsAt CTO West Coast, an expert discussed the implications of the FDA’s expedited approval programmes with a spotlight on ...
2d
Scripps News on MSNFDA committee meets to discuss COVID vaccine target for fall amid access restrictionsThe FDA's new vaccine guidelines focus on older adults, citing insufficient evidence for the need for additional COVID shots ...
The U.S. Food and Drug Administration's advisory panel is set to vote on Thursday to recommend whether COVID-19 vaccines for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results